Taub Rebecca 4

What Happened

• Rebecca Taub, a director of Madrigal Pharmaceuticals (MDGL), reported the sale of 491 shares on March 6, 2026. The shares were disposed at $431.94 per share for a total value of approximately $212,083.
• This was a sale (not a purchase); per the filing the sale was automatic to cover tax withholding on vested restricted stock units rather than an individual trading decision.

Key Details

• Transaction date and price: 2026-03-06 — 491 shares at $431.94 each.
• Total proceeds: ~$212,083.
• Shares owned after transaction: Not specified in this filing.
• Footnotes: F1 — sale made by the issuer on the reporting person’s behalf to cover tax withholding (automatic, not at the Reporting Person’s discretion). F2 — Reporting Person and spouse are managing members of SQN, LLC; Reporting Person disclaims beneficial ownership except to extent of pecuniary interest.
• Timeliness: Filing covers the transaction date 2026-03-06 and was filed on the same date (no late filing indicated).

Context

• The filing indicates a routine sell-to-cover for tax withholding related to RSU vesting, which is a common administrative transaction and does not necessarily signal the insider’s view of the company.